Factors determining extreme brain natriuretic peptide elevation. (Q48150107)

9 February 2018

title

Factors determining extreme brain natriuretic peptide elevation. (English)

1 reference

9 February 2018

author

Maya Guglin

series ordinal

1

1 reference

9 February 2018

author name string

Rayan Hourani

series ordinal

2

1 reference

9 February 2018

Sridevi Pitta

series ordinal

3

1 reference

9 February 2018

publication date

1 May 2007

1 reference

9 February 2018

published in

Congestive Heart Failure

1 reference

9 February 2018

volume

13

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

136-141

1 reference

9 February 2018

B-type natriuretic peptide and renal disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.06478.X

10.1111/J.1527-5299.2007.06478.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17541308

1 reference

9 February 2018